PL378902A1 - Doustne postaci użytkowe memantyny - Google Patents

Doustne postaci użytkowe memantyny

Info

Publication number
PL378902A1
PL378902A1 PL378902A PL37890204A PL378902A1 PL 378902 A1 PL378902 A1 PL 378902A1 PL 378902 A PL378902 A PL 378902A PL 37890204 A PL37890204 A PL 37890204A PL 378902 A1 PL378902 A1 PL 378902A1
Authority
PL
Poland
Prior art keywords
dosage forms
oral dosage
memantine oral
memantine
forms
Prior art date
Application number
PL378902A
Other languages
English (en)
Inventor
Bruce A. Firestone
Zanden John J. Vander
Janet K. Cheetham
Richard Kurjan
Teresa H. Kuan
Chin-Ming Chang
J. Abraham M. Espiritu
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Publication of PL378902A1 publication Critical patent/PL378902A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL378902A 2003-06-16 2004-06-10 Doustne postaci użytkowe memantyny PL378902A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47897903P 2003-06-16 2003-06-16

Publications (1)

Publication Number Publication Date
PL378902A1 true PL378902A1 (pl) 2006-05-29

Family

ID=33539133

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378902A PL378902A1 (pl) 2003-06-16 2004-06-10 Doustne postaci użytkowe memantyny

Country Status (16)

Country Link
US (2) US20040254251A1 (pl)
EP (1) EP1631273A1 (pl)
JP (1) JP2006527774A (pl)
KR (1) KR20060033727A (pl)
CN (1) CN1805737A (pl)
AU (1) AU2004249151A1 (pl)
BR (1) BRPI0411451A (pl)
CA (1) CA2529535A1 (pl)
IL (1) IL172233A0 (pl)
MX (1) MXPA05012810A (pl)
NO (1) NO20055880L (pl)
PL (1) PL378902A1 (pl)
RU (1) RU2006101225A (pl)
TW (1) TW200524639A (pl)
WO (1) WO2004112768A1 (pl)
ZA (1) ZA200509379B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7086532B2 (en) * 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
FR2855344A1 (fr) * 2003-05-22 2004-11-26 France Telecom Systeme de gestion de contexte pour un reseau comportant un ensemble heterogene de terminaux
CN101389315A (zh) * 2004-06-17 2009-03-18 莫茨药物股份两合公司 美金刚口服剂型即释制剂
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
EP1827385B1 (en) * 2004-11-23 2013-03-27 Adamas Pharmaceuticals, Inc. Pharmaceutical composition comprising memantine in an extended dosage release form for use in the treatment of dementias
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
RU2401125C2 (ru) 2004-12-27 2010-10-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ стабилизации лекарственного средства против деменции
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
KR101406456B1 (ko) 2005-04-06 2014-06-20 아다마스 파마슈티칼스, 인코포레이티드 Ｃｎｓ 장애의 치료를 위한 방법 및 조성물
WO2006118265A1 (ja) * 2005-04-28 2006-11-09 Eisai R & D Management Co., Ltd. 抗痴呆薬を含有する組成物
JP2009526079A (ja) * 2006-02-10 2009-07-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ カリウムチャンネル開放物質としての新規な三環式ジヒドロピラジン
US20090176736A1 (en) * 2006-04-20 2009-07-09 Katsumi Dohura Pharmaceutical composition for conformational diseases
BRPI0621789A2 (pt) * 2006-07-05 2012-05-02 Teva Pharma composições farmacêuticas com memantina
EP1908748A1 (en) * 2006-10-05 2008-04-09 Krka Process for the preparation of memantine and its hydrochloric acid salt form
US20100152108A1 (en) * 2006-10-27 2010-06-17 Medivation Neurology, Inc. Methods and combination therapies for treating alzheimer's disease
US20080182908A1 (en) * 2007-01-25 2008-07-31 Vinita Umashankar Vyas Pharmaceutical compositions comprising memantine
WO2009004440A2 (en) * 2007-06-29 2009-01-08 Orchid Chemicals & Pharmaceuticals Limited Quick dissolve compositions of memantine hydrochloride
EP2211836A2 (en) 2007-10-10 2010-08-04 Rubicon Research Private Limited Taste-masked orally disintegrating tablets of memantine hydrochloride
WO2009091932A2 (en) * 2008-01-18 2009-07-23 Adamas Pharmaceuticals, Inc. Treatment of mild dementia of the alzheimer's disease type
US20090247644A1 (en) * 2008-03-28 2009-10-01 Forest Laboratories Holdings Limited Memantine formulations
CA2782556C (en) 2009-12-02 2018-03-27 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
KR101943686B1 (ko) 2012-04-24 2019-01-29 다이이찌 산쿄 가부시키가이샤 구강내 붕괴정 및 그 제조 방법
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
KR20190076711A (ko) 2017-12-22 2019-07-02 한미약품 주식회사 메만틴을 포함하는 속방성 및 서방성을 동시에 가지는 경질캡슐 제제 및 그 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2856393C2 (de) * 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6849271B2 (en) * 2001-04-27 2005-02-01 Verion, Inc. Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods

Also Published As

Publication number Publication date
ZA200509379B (en) 2006-11-29
TW200524639A (en) 2005-08-01
KR20060033727A (ko) 2006-04-19
CA2529535A1 (en) 2004-12-29
AU2004249151A1 (en) 2004-12-29
NO20055880L (no) 2005-12-28
CN1805737A (zh) 2006-07-19
EP1631273A1 (en) 2006-03-08
BRPI0411451A (pt) 2006-07-18
RU2006101225A (ru) 2006-06-10
MXPA05012810A (es) 2006-02-13
IL172233A0 (en) 2006-04-10
US20060251717A1 (en) 2006-11-09
US20040254251A1 (en) 2004-12-16
JP2006527774A (ja) 2006-12-07
WO2004112768A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
ZA200509379B (en) Memantine oral dosage forms
GB0322284D0 (en) Medicament dispenser
AU2003244650A8 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
HK1107768A1 (en) Solid drug for oral use
IL174342A0 (en) Chronotherapeutic dosage forms
GB0324886D0 (en) Medicinal compounds
IL172824A0 (en) Pharmaceutical formulations
EP1553925A4 (en) ORAL DOSAGE FORM WITH MODIFIED RELEASE
GB0302671D0 (en) Pharmaceutical formulations
AU2003238670A8 (en) Fast disintegrating oral dosage forms
GB0303396D0 (en) Medicinal compounds
GB0209668D0 (en) Oral devices
GB0302672D0 (en) Pharmaceutical formulations
GB0328490D0 (en) Medicinal compounds
HK1092715A1 (en) Melt-formulated, multi-particulate oral dosage form
GB0325383D0 (en) Oral formulations
GB0206505D0 (en) Pharmaceutical combination
GB0316341D0 (en) Pharmaceutical formulations
EP1614417A4 (en) SOLID PREPARATION FOR ORAL USE
PL373409A1 (pl) Kombinacja farmaceutyczna
ZA200600560B (en) Combined doses
GB0315019D0 (en) Dosage form
GB0316335D0 (en) Pharmaceutical formulations
GB0220451D0 (en) Pharmaceutical use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)